UK’s largest stock-market-listed firm weighs up Hong Kong or Shanghai listing to shield it from geopolitical tensions
Business live – latest updates
AstraZeneca is considering spinning off its business in China and listing it in Hong Kong or Shanghai to shield the multinational drugmaker from geopolitical tensions.
Britain’s largest stock-market-listed company has drawn up the plans in attempt to protect its business from the fallout from increasing tensions between China and the US and its allies.
About Author
More Stories
BYD launches cheapest UK model in bid to overtake Tesla as biggest electric carmaker
Trump trade deal shows how vital China’s rare-earth metals are to US defense firms
Oil and gold prices soar and stock markets fall after Israel’s attacks on Iran